Ra Capital Management, L.P. Black Diamond Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

  • $7.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$1.77 - $3.03 $6.24 Million - $10.7 Million
3,525,754 New
3,525,754 $9.91 Million
Q2 2023

Aug 14, 2023
BUY
$1.43 - $6.18 $1.34 Million - $5.78 Million
935,850 Added 36.13%
3,525,754 $17.8 Million
Q1 2020

May 15, 2020
BUY
$18.18 - $39.48 $47.1 Million - $102 Million
2,589,904 New
2,589,904 $64.6 Million

Others Institutions Holding BDTX

# of Institutions
118
Shares Held
48.9M
Call Options Held
1.84M
Put Options Held
1.93M
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $81M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email